跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ONKOTRONE mitozantrone 30mg/15mL (as hydrochloride) concentrated injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
ONKOTRONE mitozantrone 30mg/15mL (as hydrochloride) concentrated injection vial
Approved
STANDARD
ONKOTRONE mitozantrone 30mg/15mL (as hydrochloride) concentrated injection vial
Baxter Healthcare Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
de4c8aa4d10132f3
Company
Baxter Healthcare Pty Ltd
Type
Standard
Approval Details
Approval Id
de4c8aa4d10132f3
Product Name
ONKOTRONE mitozantrone 30mg/15mL (as hydrochloride) concentrated injection vial
Artg Id
75725
Artg Name
ONKOTRONE mitozantrone 30mg/15mL (as hydrochloride) concentrated injection vial
Sponsor
Baxter Healthcare Pty Ltd
Company Detail Path
/organization/baxter-healthcare-pty-ltd
Artg Date
2001-01-24
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/a37cc8581d300de3322106638295df54.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/1705772100e3ec8bf08354fd3b47829c.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
de4c8aa4d10132f3
Type
Standard
Back to TGA Approvals